1. Home
  2. QNRX vs GNLN Comparison

QNRX vs GNLN Comparison

Compare QNRX & GNLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNRX
  • GNLN
  • Stock Information
  • Founded
  • QNRX 2018
  • GNLN 2005
  • Country
  • QNRX United States
  • GNLN United States
  • Employees
  • QNRX N/A
  • GNLN N/A
  • Industry
  • QNRX Medical/Dental Instruments
  • GNLN Durable Goods
  • Sector
  • QNRX Health Care
  • GNLN Consumer Discretionary
  • Exchange
  • QNRX Nasdaq
  • GNLN Nasdaq
  • Market Cap
  • QNRX 2.5M
  • GNLN 2.3M
  • IPO Year
  • QNRX N/A
  • GNLN 2019
  • Fundamental
  • Price
  • QNRX $7.12
  • GNLN $0.01
  • Analyst Decision
  • QNRX
  • GNLN
  • Analyst Count
  • QNRX 0
  • GNLN 0
  • Target Price
  • QNRX N/A
  • GNLN N/A
  • AVG Volume (30 Days)
  • QNRX 355.0K
  • GNLN 39.7M
  • Earning Date
  • QNRX 05-08-2025
  • GNLN 03-21-2025
  • Dividend Yield
  • QNRX N/A
  • GNLN N/A
  • EPS Growth
  • QNRX N/A
  • GNLN N/A
  • EPS
  • QNRX N/A
  • GNLN N/A
  • Revenue
  • QNRX N/A
  • GNLN $13,275,000.00
  • Revenue This Year
  • QNRX N/A
  • GNLN $1,541.21
  • Revenue Next Year
  • QNRX N/A
  • GNLN N/A
  • P/E Ratio
  • QNRX N/A
  • GNLN N/A
  • Revenue Growth
  • QNRX N/A
  • GNLN N/A
  • 52 Week Low
  • QNRX $5.01
  • GNLN $0.01
  • 52 Week High
  • QNRX $54.95
  • GNLN $21.80
  • Technical
  • Relative Strength Index (RSI)
  • QNRX 46.54
  • GNLN 18.47
  • Support Level
  • QNRX $5.27
  • GNLN $0.21
  • Resistance Level
  • QNRX $7.22
  • GNLN $0.29
  • Average True Range (ATR)
  • QNRX 1.12
  • GNLN 0.03
  • MACD
  • QNRX 0.22
  • GNLN -0.00
  • Stochastic Oscillator
  • QNRX 62.79
  • GNLN 0.32

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.

Share on Social Networks: